Karina Haar Jensen

[Karina Haar Jensen @KarinaHaar]

I am investigating epidemiology, diagnostic accuracy, and prognostic markers within biopsy verified #diabeticnephropathy within the #PRIMETIME (PRecIsion MEdicine based on kidney TIssue Molecular interrogation in diabetic nEphropathy) project

[Karina Haar Jensen @KarinaHaar]

@MarieMoeller_DK
@FrederikPersson
@IBressendorff
@DitteHansen7
@RikkeBorg
@P_Rossing

[Karina Haar Jensen @KarinaHaar]

I am investigating epidemiology, diagnostic accuracy, and prognostic markers within biopsy verified #diabeticnephropathy within the #PRIMETIME (PRecIsion MEdicine based on kidney TIssue Molecular interrogation in diabetic nEphropathy) project

[Karina Haar Jensen @KarinaHaar]

@BMJ_Open https://t.co/g19ESqFxOC

[Frederik Persson @FrederikPersson]

We created a retrospective kidney biopsy cohort and will investigate clinical, molecular data and association to outcome. @KarinaHaar leads the work with @DitteHansen7 @P_Rossing @RikkeBorg @MarieMoeller_DK @IBressendorff @KosjerinaVanja @Stenodiabetes https://t.co/YbopnDlYJX